Pharma Marketing Network

Now is a good time to look into our crystal balls and predict the future scenarios for the pharmaceutical industry. Let's take a slightly long-term view and predict how likely several scenarios will unfold in the next 5 to 8 years (ie, 2012 to 2019)

This survey asks your opinion whether or not the certain specific gifts to physicians create conflicts of interest.

This survey asked respondents for input on various cost-cutting and ROI strategies available to the pharmaceutical industry, how likely any of these will be adopted in the near future, and what the effect may be upon pharmaceutical marketers.

Do CME activities that accept commercial support from pharmaceutical companies have more bias that activities that don't?

I've been hearing a lot of criticism of pharma marketing buzzwords lately and wonder what marketing professionals like you think of the many buzzwords commonly used by the pharmaceutical industry today.

The PhRMA Code's Impact on Interactions with Healthcare Professionals

Recently, pharma companies appear to be using more patient testimonials in their DTC (direct-to-consumer) broadcast and social media advertising. This survey asks your opinion of this practice, including what the benefits may be, the regulatory issues, and how it may evolve, especially with regard to use of social media.

This survey asks YOUR opinion about best practices that you think should govern pharma's collaboration with online

Please take 2 minutes to answer this survey, which asks your opinion specifically of the FDA's proposed rule and of off-label drug promotion in general.

The authors of a #MICEproject research report propose six activities that medical conference organizers should consider in order to draft appropriate future guidelines for third party activities in Twitter backchannels. Tell us YOUR opinion regarding these activities.